동물 백신 시장 규모, 점유율 및 성장 분석 : 백신 유형별, 동물 유형별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Animal Vaccines Market size was valued at USD 7.8 Billion in 2024 and is poised to grow from USD 8.32 Billion in 2025 to USD 13.98 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The market for global animal vaccines is experiencing significant growth due to heightened outbreaks of animal diseases and a rising livestock population worldwide. This growth is fueled by a demand for essential animal products, including meat, milk, and leather. Key vaccines, such as those for rabies, equine influenza, and foot-and-mouth disease, play a vital role in preventing the spread of infectious diseases by enhancing immune response. Concerns about food security and the evolving landscape of animal husbandry are driving further demand for effective livestock vaccines. Additionally, changing lifestyles and dietary preferences linked to population growth are influencing the need for livestock products. The ongoing development of advanced vaccines, alongside disease outbreaks, is reshaping the dynamics within the animal vaccines market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Vaccines Market Segments Analysis

Global Animal Vaccines Market is segmented by Vaccine Type, Animal Type, Administration Route, End User and region. Based on Vaccine Type, the market is segmented into Live Attenuated Vaccines, Inactivated Vaccines and Recombinant Vaccines. Based on Animal Type, the market is segmented into Pets and Livestock. Based on Administration Route, the market is segmented into Injectable, Intranasal and Oral. Based on End User, the market is segmented into Veterinary Clinics, Farmers and Research Institutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Vaccines Market

The rising occurrence of zoonotic diseases poses significant threats to both human health and agriculture, driving the demand for animal vaccines. The emergence of new and exotic diseases adds urgency to addressing health risks for both animals and humans, while also impacting food security. As human and animal populations continue to grow, alongside environmental degradation and the globalization of trade and travel, the likelihood of pathogen transmission between species escalates. This situation creates substantial challenges related to disease management and prevention, highlighting the crucial need for effective vaccination solutions to safeguard both animal and human health in a rapidly changing world.

Restraints in the Global Animal Vaccines Market

The Global Animal Vaccines market faces significant constraints, particularly in developing regions such as Africa, Asia, and Latin America, where an estimated 600-900 million smallholder farmers raise livestock. Adoption of animal vaccinations within this demographic is hindered by several challenges, including a lack of awareness regarding the advantages of immunization, limited access due to high costs of vaccines, and an inadequate supply chain that restricts availability. Consequently, many livestock owned by these farmers succumb to preventable diseases, exacerbating their economic hardships. To address these issues, various initiatives are underway aimed at enhancing vaccine accessibility, availability, and affordability for smallholder farmers.

Market Trends of the Global Animal Vaccines Market

The Global Animal Vaccines market is witnessing a significant upward trend driven by an increase in public-private funding aimed at targeted research initiatives and a surge in the prevalence of animal diseases. This is further propelled by innovative product developments spurred by technological advancements. The market landscape is becoming increasingly favorable, with strategic alliances on the rise, enhanced internet penetration fueling information dissemination, and growing public concern over zoonotic diseases. Additionally, advances in diagnostics and therapeutics, particularly in developing regions, combined with a rise in per capita healthcare expenditure, are creating promising opportunities for stakeholders in this dynamic market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Animal Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Live Attenuated Vaccines
• Inactivated Vaccines
• Recombinant Vaccines

Global Animal Vaccines Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Pets
  • Dogs
  • Cats
• Livestock
  • Cattle
  • Pigs

Global Animal Vaccines Market Size by Administration Route & CAGR (2026-2033)

• Market Overview
• Injectable
• Intranasal
• Oral

Global Animal Vaccines Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Farmers
• Research Institutions

Global Animal Vaccines Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Animal Type, Administration Route, End User)
  • US
  • Canada
• Europe (Vaccine Type, Animal Type, Administration Route, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Animal Type, Administration Route, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Animal Type, Administration Route, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Animal Type, Administration Route, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HIPRA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TheraCell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Provimi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrivet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanti International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parnell Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animal Health International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DVM Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations